Shire buoyed by Alzheimer's

Shire Pharmaceuticals Group (LSE:SHP) is the only U.K. bioscience stock on the London Stock Exchange to be trading anywhere near its 52-week high. The explanation is fairly simple: the market is enamored with the company's progress with its Reminyl galantamine, a second generation acetyl cholinesterase inhibitor being

Read the full 476 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers